FDA Inspection 756562 — Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd.
The FDA completed an inspection of Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd. on November 11, 2011 in Singapore. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 11, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Singapore (Singapore)